Preliminary results of active specific immunization with modified tumor cell vaccine in glioblastoma multiforme
/in Glioblastoma, International Publications, Newcastle Disease VirusVaccination of malignant glioma patients with peptide-pulsed dendritic cells elicits systemic cytotoxicity and intracranial T-cell infiltration
/in Dendritic Cells, Glioblastoma, International PublicationsTreatment of a patient by vaccination with autologous dendritic cells pulsed with allogeneic major histocompatibility complex class I-matched tumor peptides. Case Report
/in Dendritic Cells, Glioblastoma, International PublicationsUse of Newcastle disease virus vaccine (MTH-68/H) in a patient with high-grade glioblastoma
/in Glioblastoma, International Publications, Newcastle Disease VirusHyperthermia–its actual role in radiation oncology. Part IV: Thermo-radiotherapy for malignant brain tumors
/in Glioblastoma, Hyperthermia, International PublicationsTreatment of malignant gliomas with interstitial irradiation and hyperthermia
/in Glioblastoma, Hyperthermia, International Publications[Radiofrequency hyperthermia in malignant brain tumors: clinical trials]
/in Glioblastoma, Hyperthermia, International Publications[Local hyperthermia of malignant brain tumors]
/in Glioblastoma, Hyperthermia, International PublicationsCombination radiofrequency hyperthermia and chemotherapy (BCNU) for brain malignancy. Animal experience and two case reports
/in Glioblastoma, Hyperthermia, International Publications
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome
- Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma patients: a systematic review of literature
- Retrospective Analysis of HLA Class II-Restricted Neoantigen Peptide-Pulsed Dendritic Cell Vaccine for Breast Cancer